Tequin

July 23, 2008

A tentative settlement has been reached in the Tequin class action on a Canada-wide basis. For more details, please click here. Once the settlement has received court approval, we will provide further information on this web page.

February 23, 2007

The Class Action lawsuit against Bristol-Myers Squibb relating to Tequin has been filed in British Columbia today.

To read the Statement of claim, please click here.

June 12, 2006

A Class Action lawsuit has been commenced in Ontario relating to Tequin, an antibiotic manufactured by Bristol-Myers Squibb.  In this lawsuit, it is alleged that the use of Tequin can cause an increased risk of potentially life-threatening blood sugar fluctuations.

Tequin (gatifloxacin) is an antibiotic typically prescribed to treat pneumonia and other infections including those of the bladder, urinary tract and sinuses and for sexually transmitted diseases. Recent studies suggest that in a certain number of people, ingesting Tequin often results in being treated in emergency departments or hospitalized for blood sugar disorders.

If you or someone close to you has used the drug Tequin, and wish to receive further information regarding the lawsuit, please contact Poyner Baxter LLP at 604 988-6321 or by email to classaction@poynerbaxter.com.

Click here to read the CTV News article about this lawsuit.

This Web site is offered for information only and is not legal advice. Use of the site and sending or receiving information through it does not establish an attorney-client relationship. No one should act, or refrain from acting, based solely upon this information without seeking appropriate legal or other professional advice. In particular, you should obtain advice about limitation periods as it may affect your right to bring a legal action on your own behalf. Links to and from from this Web site do not state or imply a relationship between Poyner Baxter LLP and the linked entity.

Back